DE2656374C2 - - Google Patents

Info

Publication number
DE2656374C2
DE2656374C2 DE2656374A DE2656374A DE2656374C2 DE 2656374 C2 DE2656374 C2 DE 2656374C2 DE 2656374 A DE2656374 A DE 2656374A DE 2656374 A DE2656374 A DE 2656374A DE 2656374 C2 DE2656374 C2 DE 2656374C2
Authority
DE
Germany
Prior art keywords
amino
compounds
carbon atoms
hydrogen atom
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2656374A
Other languages
German (de)
English (en)
Other versions
DE2656374A1 (de
Inventor
Edward Jethro Lansdale Pa. Us Cragoe Jun.
Otto William Chalfont Pa. Us Woltersdorf Jun.
Charles Newcomer Lansdale Pa. Us Habecker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2656374A1 publication Critical patent/DE2656374A1/de
Application granted granted Critical
Publication of DE2656374C2 publication Critical patent/DE2656374C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE19762656374 1975-12-15 1976-12-13 Pyrazincarboxamide und verfahren zu ihrer herstellung Granted DE2656374A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64080375A 1975-12-15 1975-12-15

Publications (2)

Publication Number Publication Date
DE2656374A1 DE2656374A1 (de) 1977-06-16
DE2656374C2 true DE2656374C2 (enExample) 1989-08-10

Family

ID=24569755

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762656374 Granted DE2656374A1 (de) 1975-12-15 1976-12-13 Pyrazincarboxamide und verfahren zu ihrer herstellung

Country Status (14)

Country Link
US (1) US4085211A (enExample)
JP (1) JPS52106877A (enExample)
AU (1) AU511429B2 (enExample)
BE (1) BE849379A (enExample)
CH (1) CH630369A5 (enExample)
DE (1) DE2656374A1 (enExample)
DK (1) DK531476A (enExample)
ES (2) ES454160A1 (enExample)
FR (1) FR2335226A1 (enExample)
GB (1) GB1527297A (enExample)
HU (1) HU175504B (enExample)
NL (1) NL7613276A (enExample)
SE (1) SE431452B (enExample)
ZA (1) ZA767431B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9586911B2 (en) 2013-12-13 2017-03-07 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epthelial sodium channel blocking compounds
US9593084B2 (en) 2012-12-17 2017-03-14 Parion Sciences, Inc. Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208413A (en) * 1977-03-04 1980-06-17 Merck & Co., Inc. N-Pyrazinecarbonyl-N'-alkoxycarbonyl and N',N"-bis(alkoxycarbonyl)guanidines and processes for preparing same
US4163781A (en) * 1978-04-17 1979-08-07 Merck & Co., Inc. 3-Amino-N-[(phosphonoamino)iminomethyl]-6-halopyrazinecarboxamide compounds, compositions and methods of use
EP0009054A1 (en) * 1978-09-19 1980-04-02 Merck & Co. Inc. N-Pyrazinecarbonyl-N'-substituted-sulfamoyl-guanidine and processes for preparing same
US4277602A (en) * 1980-07-02 1981-07-07 Merck & Co., Inc. 3-Amino-5-substituted-6-halo-N-(3,4-dihydro-6-substituted-1,3,5-truazin-2-yl)2-pyrazinecarboxamides
US4272537A (en) * 1980-07-02 1981-06-09 Merck & Co., Inc. 3-Amino-5-substituted-6-halo-N-(4,4-disubstituted-6-substituted-1,3,5-triazin-2-yl)-2-pyrazinecarboxamides
FI820266L (fi) * 1981-02-02 1982-08-03 Ici Plc Alkanolaminderivater
US4594349A (en) * 1982-01-04 1986-06-10 Beyer Jr Karl H Hyperuretic agents
JPS62291361A (ja) * 1986-06-09 1987-12-18 株式会社ブリヂストン 床支持装置
JPS6342741U (enExample) * 1986-09-04 1988-03-22
GB8810933D0 (en) * 1987-05-26 1988-06-15 Ici America Inc Heterocyclic compounds
GB8810934D0 (en) * 1987-05-26 1988-06-15 Ici America Inc Amides
GB8812343D0 (en) * 1988-05-25 1988-06-29 Ici America Inc Amino compounds
GB8812342D0 (en) * 1988-05-25 1988-06-29 Ici America Inc Bicyclic compounds
JPH02101937U (enExample) * 1989-01-31 1990-08-14
AUPP646498A0 (en) * 1998-10-12 1998-11-05 Australian National University, The A method of modulating ion channel functional activity
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6858614B2 (en) * 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenolic guanidine sodium channel blockers
US6903105B2 (en) * 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US20050090505A1 (en) * 2003-08-18 2005-04-28 Johnson Michael R. Methods of reducing risk of infection from pathogens
US7745442B2 (en) 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
US20090253714A1 (en) * 2003-08-20 2009-10-08 Johnson Michael R Methods of reducing risk of infection from pathogens
WO2006023617A2 (en) * 2004-08-18 2006-03-02 Johnson Michael R Cyclic amide & ester pyrazinoylguanidine sodium channel blockers
US20070021439A1 (en) * 2005-07-25 2007-01-25 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers
GB0526244D0 (en) * 2005-12-22 2006-02-01 Novartis Ag Organic compounds
EA017919B1 (ru) * 2007-12-10 2013-04-30 Новартис Аг Производные пиразин-2-карбоксамида для лечения заболеваний, которые поддаются лечению путем блокирования эпителиальных натриевых каналов
DE102008053024B4 (de) 2008-10-24 2015-04-30 RUHR-UNIVERSITäT BOCHUM Verwendung von Amilorid-Derivaten zur Bekämpfung von Insekten und Milben
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
AU2013363215B2 (en) 2012-12-17 2018-03-01 Parion Sciences, Inc. 3,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
CN107003568B (zh) * 2014-09-18 2020-09-15 日产化学工业株式会社 液晶取向剂、液晶取向膜和液晶表示元件

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE639386A (enExample) * 1962-10-30
BE639393A (enExample) * 1962-10-30

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9593084B2 (en) 2012-12-17 2017-03-14 Parion Sciences, Inc. Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity
US9586911B2 (en) 2013-12-13 2017-03-07 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epthelial sodium channel blocking compounds

Also Published As

Publication number Publication date
BE849379A (fr) 1977-06-14
SE431452B (sv) 1984-02-06
US4085211A (en) 1978-04-18
JPS52106877A (en) 1977-09-07
NL7613276A (nl) 1977-06-17
GB1527297A (en) 1978-10-04
AU2018176A (en) 1978-06-08
FR2335226A1 (fr) 1977-07-15
JPS6238350B2 (enExample) 1987-08-17
CH630369A5 (de) 1982-06-15
HU175504B (hu) 1980-08-28
ES465742A1 (es) 1978-10-01
DE2656374A1 (de) 1977-06-16
SE7613289L (sv) 1977-06-16
ES454160A1 (es) 1978-03-01
DK531476A (da) 1977-06-16
AU511429B2 (en) 1980-08-21
ZA767431B (en) 1978-07-26
FR2335226B1 (enExample) 1979-03-09

Similar Documents

Publication Publication Date Title
DE2656374C2 (enExample)
DE1795062A1 (de) 1H-Imidazo[4,5-b]pyrazin-2-one und Verfahren zu ihrer Herstellung
DE2936705A1 (de) Neue 4-anilinochinazolinderivate, verfahren zu deren herstellung und diese enthaltende arzneimittel
DD211560A5 (de) Verfahren zur herstellung kristalliner benzothiazindioxid-salze
DE2849537C2 (de) Substituierte 5-(2-Imidazolin-2-yl)-aminopyrimidine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
CH642964A5 (de) 1-substituierte 4-(chinolinylaminobenzoyl)-piperazine sowie diese verbindungen enthaltende arzneimittel.
DE3125471C2 (de) Piperazinderivate, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
DE2847792A1 (de) N-4-chinolyl-guanidine, verfahren zu deren herstellung und pharmazeutische mittel
DE2233458A1 (de) Neue chinolinderivate
EP0180115A2 (de) 1,2,4-Triazolo-carbamate und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und Arzneimittel
DE1956891A1 (de) Chemische Verfahren und Produkte
CH634060A5 (de) Verfahren zur herstellung neuer (3-amino-5-substituierter-6-fluorpyrazinoyl- oder -pyrazinamido)-guanidine und deren derivate.
EP0126296B1 (de) Substituierte Phenyl-2-(1H)-pyrimidinone, Verfahren zu ihrer Herstellung und ihre Verwendung sowie diese Verbindungen enthaltende Zubereitungen
EP0317855B1 (de) Pharmazeutische Präparate
DE1568349A1 (de) Neue Diphenylharnstoffe und Verfahren zu ihrer Herstellung
EP0072954B1 (de) Isoindolin-2-yl-amino-imidazoline und Isoindolin-2-yl-guanidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE3152942T1 (de) Heterocyclisch substituierte amidinoharnstoffe und ihre therapeutische anwendung
DE1963317A1 (de) Chemische Verfahren und Produkte
EP0097297B1 (de) Substituierte 5-Phenylthio-6-amino-pyrimidinone, Verfahren zu ihrer Herstellung und ihre Verwendung sowie diese Verbindungen enthaltende Zubereitungen
DE4019080A1 (de) Neue 3,7-diazabicycolo (3,3,1)nonan-verbindungen enthaltende arzneimittel
DE2243789A1 (de) 1-aminoisochinolinderivate, ihre salze mit saeuren und quartaeren ammoniumsalze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0037471B1 (de) 1-Aroyl-2-phenylamino-2-imidazoline, ihre Herstellung und diese enthaltende Arzneimittel
DE3105122A1 (de) Neue piperazin-verbindungen, verfahren zu ihrer herstellung und ihre verwendung
DE2314488A1 (de) Neue imidazo eckige klammer auf 1,2-a eckige klammer zu s-triazine, diese enthaltende arzneimittel, sowie verfahren zu deren herstellung
DE2914051A1 (de) Antiarthritisches mittel und verfahren zur herstellung desselben

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: ABITZ, W., DIPL.-ING.DR.-ING. MORF, D., DR., PAT.-

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee